CHAMPIONS ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.02 USD | -0.79% |
|
-0.79% | -10.67% |
| 15/03 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
| 13/03 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Chart calendar Champions Oncology, Inc.
5c743a586c735ca0.D2nkpQ0Xg_V2bxKhjd2DzVbIDLXa1rThXxgPgeit7gQ.XTGXk1lf1aYaIlnStbPMnAOKOI21pfOrD0dI76aYsVZNK4n1P1TGuiIXfQ~ca491da6423cc7e6dabba920679e601c
Upcoming events on Champions Oncology, Inc.
Past events on Champions Oncology, Inc.
| 13/03/2024 02:00 am | Q3 2024 Earnings Call |
| 13/03/2024 02:00 am | Q3 2024 Earnings Release |
| 13/12/2023 03:00 am | Q2 2024 Earnings Call |
| 13/12/2023 02:30 am | Q2 2024 Earnings Release |
| 19/10/2023 | Annual General Meeting |
| 26/09/2023 | Translational Oncology Symposium |
| 14/09/2023 02:00 am | Q1 2024 Earnings Call |
| 14/09/2023 01:30 am | Q1 2024 Earnings Release |
| 25/07/2023 02:00 am | Q4 2023 Earnings Call |
| 25/07/2023 01:30 am | Q4 2023 Earnings Release |
| 19/07/2023 | Japanese Association for Cancer Immunology Scientific Conference |
| 12/07/2023 | Tumor Models Scientific Conference |
| 16/03/2023 02:00 am | Q3 2023 Earnings Call |
| 16/03/2023 01:20 am | Q3 2023 Earnings Release |
| 14/12/2022 03:00 am | Interim 2023 Earnings Call |
| 14/12/2022 02:30 am | Interim 2023 Earnings Release |
| 20/10/2022 | Annual General Meeting |
| 09/09/2022 02:00 am | Q1 2023 Earnings Call |
| 09/09/2022 01:30 am | Q1 2023 Earnings Release |
| 22/07/2022 02:00 am | FY 2022 Earnings Call |
Annual results
| Fiscal Period | April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 27,1 25,8 4.95% | 32,1 31,7 1.46% | 41,0 40,5 1.32% | 49,1 48,9 0.34% | 53,9 53,7 0.39% | 48,8 |
|
EBITDA Million USD | Released Forecast Spread | 0,88 0,79 11.03% | -1,02 0,88 -215.65% | 1,52 1,18 28.55% | 2,21 2,80 -21.04% | -2,16 -2,04 -5.94% | -6,56 |
|
EBIT Million USD | Released Forecast Spread | 0,27 0,70 -61.43% | -1,80 0,23 -868.31% | 0,34 0,54 -36.82% | 0,61 1,32 -53.93% | -5,26 -4,71 -11.55% | -9,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,23 0,24 -3.95% | -1,85 0,35 -634.78% | 0,41 0,60 -31.53% | 0,58 1,34 -56.39% | -5,27 -4,69 -12.36% | -9,53 |
|
Net income Million USD | Released Forecast Spread | 0,13 0,70 -81.71% | -1,98 0,29 -776.37% | 0,33 0,84 -60.36% | 0,55 1,23 -55.48% | -5,34 -4,46 -19.53% | 0,00 |
|
EPS USD | Released Forecast Spread | 0,01 0,06 -83.33% | -0,17 0,03 -780% | 0,02 0,06 -66.67% | 0,04 0,09 -52.94% | -0,39 -0,33 -18.18% | 0,00 |
| Announcement Date | 15/07/19 | 27/07/20 | 22/07/21 | 21/07/22 | 24/07/23 | - |
Quarterly results
| Fiscal Period | April | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,2 12,5 5.81% | 12,9 12,7 1.21% | 13,7 13,2 4.19% | 14,3 13,9 2.42% | 12,8 13,1 -2.74% | 13,1 12,9 1.64% | 12,6 13,1 -3.85% | 11,6 12,8 -9.78% | 12,0 13,5 -10.81% | 12,7 | 13,1 | 13,3 | 13,5 | 13,7 |
|
EBITDA Million USD | Released Forecast Spread | 1,19 0,77 54.86% | 0,22 0,81 -72.63% | 0,23 0,40 -43.78% | 0,69 0,85 -19.67% | -1,52 0,07 -2396.97% | -1,75 -1,63 -7.37% | -1,67 -1,20 -38.82% | -1,42 -1,83 22.64% | -1,66 -0,31 -433.44% | -1,71 | -0,82 | -0,78 | -0,42 | -0,63 |
|
EBIT Million USD | Released Forecast Spread | 0,83 0,45 84.31% | -0,31 0,40 -177.81% | -0,28 0,01 -2403.33% | 0,01 -0,04 118.58% | -2,46 -0,57 -333% | -2,52 -1,98 -27.54% | -2,55 -1,74 -47.05% | -1,96 -2,36 17.21% | -2,58 -1,15 -124.09% | -2,42 | -1,57 | -1,48 | -1,27 | -1,36 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,80 0,46 73.98% | -0,35 0,41 -184.8% | -0,30 0,02 -1561.05% | 0,00 -0,04 95.31% | -2,42 -0,57 -325.41% | -2,54 -1,96 -29.53% | -2,54 -1,71 -48.16% | -2,06 -2,35 12.2% | -2,52 -1,15 -120% | -2,41 | -1,56 | -1,47 | -1,27 | -1,35 |
|
Net income Million USD | Released Forecast Spread | 0,79 0,42 86.05% | -0,34 0,34 -201.47% | -0,32 0,11 -394.01% | -0,02 -0,06 71.26% | -2,44 -0,44 -454.95% | -2,56 -1,69 -51.58% | -2,57 -1,41 -81.99% | -2,07 -2,30 9.88% | ||||||
|
EPS USD | Released Forecast Spread | 0,05 0,03 100% | -0,02 0,03 -180% | -0,02 0,01 -300% | 0,00 0,01 - | -0,18 -0,04 -414.29% | -0,19 -0,13 -52% | -0,19 -0,10 -90% | -0,15 -0,17 11.76% | ||||||
| Announcement Date | 15/03/22 | 21/07/22 | 12/09/22 | 13/12/22 | 15/03/23 | 24/07/23 | 13/09/23 | 12/12/23 | 12/03/24 | - | - | - | - | - |
More events
Past sector events for Champions Oncology, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CSBR Stock
- Calendar Champions Oncology, Inc.
